Sree Rayalaseema Hi-Strength Hypo
539.80
+2.95(+0.55%)
Market Cap₹926.56 Cr
PE Ratio10.10
IndustryChemicals
Company Performance:
1D+0.55%
1M+12.18%
6M+5.54%
1Y-6.61%
5Y+82.33%
View Company Insightsright
More news about Sree Rayalaseema Hi-Strength Hypo
14Feb 26
Sree Rayalaseema Hi-Strength Hypo Reports Q3FY26 Financial Results with Revenue of ₹14,117.40 Lakhs
Sree Rayalaseema Hi-Strength Hypo Limited reported Q3FY26 results with revenue from operations at ₹14,117.40 lakhs and net profit of ₹2,434.69 lakhs. For nine months ended December 31, 2025, revenue reached ₹50,381.93 lakhs with net profit of ₹7,212.37 lakhs, showing growth over previous year. The company operates primarily in chemicals segment with facilities in India.
 no imag found
30May 25
SREE RAYALASEEMA HI-STRENGTH HYPO Announces Dividend and Reports Mixed Q4 Results
SREE RAYALASEEMA HI-STRENGTH HYPO has released its Q4 financial results, showing a decrease in EBITDA to ₹179.00 million from ₹271.00 million year-over-year. The EBITDA margin contracted to 11.17% from 16.39%. Despite the decline, the company declared a dividend of 3.00 rupees per share.
 no imag found
1 Year Returns:-6.61%
Industry Peers
Tata Chemicals
783.90
(+2.34%)
GHCL
458.45
(+3.42%)
TANFAC Industries
1,981.15
(-2.76%)
Chemplast Sanmar
230.75
(-5.39%)
Grauer & Weil
75.02
(+10.16%)
Thirumalai Chemicals
213.07
(+1.00%)